Inventor
AKAHATA WATARU
US22 patents
⚠️ This page may combine multiple inventors who share the name “AKAHATA WATARU”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
VLP THERAPEUTICS LLC
8 patentsUS9249191B2Feb 2, 2016
Virus like particle composition
VLP THERAPEUTICS LLC23 citations92
US9969986B2May 15, 2018
Virus like particle comprising modified envelope protein E3
VLP THERAPEUTICS LLC11 citations83
US9637532B2May 2, 2017
Virus like particle comprising PD-1 antigen or PD-1 ligand antigen
VLP THERAPEUTICS LLC9 citations83
US9512190B2Dec 6, 2016
Malaria vaccine
VLP THERAPEUTICS LLC14 citations83
US10166281B2Jan 1, 2019
Method and composition for modulating immune response
VLP THERAPEUTICS LLC3 citations72
US10098943B2Oct 16, 2018
Flavivirus virus like particle
VLP THERAPEUTICS LLC5 citations72
US10464986B2Nov 5, 2019
Virus like particle comprising PD-1 antigen or PD-1 ligand antigen
VLP THERAPEUTICS LLC0 citations51
US10385101B2Aug 20, 2019
Virus like particle comprising modified envelope protein E3
VLP THERAPEUTICS LLC0 citations51
US HEALTH
5 patentsUS10369208B2Aug 6, 2019
Methods for the induction of immune responses in a subject compromising administering virus-like particles (VLPS) prepared from Chikungunya virus structural proteins
US HEALTH5 citations84
US11718647B2Aug 8, 2023
Virus-like particles and methods of use
US HEALTH2 citations73
US10138277B2Nov 27, 2018
Virus-like particles and methods of use
US HEALTH3 citations73
US12281336B2Apr 22, 2025
Chikungunya virus (CHIKV) virus-like particles (VLPS) comprising the C, E1, and E2 structural proteins
US HEALTH0 citations62
US12168675B2Dec 17, 2024
Virus-like particles and methods of use
US HEALTH0 citations62
VLP THERAPEUTICS INC
4 patentsUS12280102B2Apr 22, 2025
Alphavirus replicon encoding chimeric SARS-CoV-2 receptor binding domains
VLP THERAPEUTICS INC0 citations60
US12227770B2Feb 18, 2025
Alphavirus replicon particle
VLP THERAPEUTICS INC0 citations60
US12134777B2Nov 5, 2024
Alphavirus replicon vector and immunotherapy by administering same
VLP THERAPEUTICS INC0 citations60
US11345726B2May 31, 2022
Chikungunya virus (CHIKV) or Venezuelan equine encephalitis virus (VEEV) virus-like particles comprising heterologous antigens inserted into the envelope protein
VLP THERAPEUTICS INC0 citations60
NABEL GARY J
2 patentsTHE USA AS REPRESENTED BY THE SEC DEP OF HEALTH AND HUMAN SERVICES
2 patentsUS11098084B2Aug 24, 2021
Virus-like particles and methods of use
THE USA AS REPRESENTED BY THE SEC DEP OF HEALTH AND HUMAN SERVICES3 citations72
US11369674B2Jun 28, 2022
Treatment method utilizing chikungunya virus (CHIKV) virus-like particles (VLPS) comprising the C, E2 and E1 structural proteins
THE USA AS REPRESENTED BY THE SEC DEP OF HEALTH AND HUMAN SERVICES0 citations62